Analysts have gone cold on corporate executives as they climb a wall of worry that includes soaring labour costs, surging prices for raw materials, rising borrowing rates and heightening geopolitical tensions that have shown no signs of abating.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale